Correction to: Improvements in Cognitive Processing Speed, Disability, and Patient‑Reported Outcomes in Patients with Early Relapsing‑Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4‑year, Real‑World, Open‑Label Study

Autor: Jai Perumal, Roumen Balabanov, Ray Su, Roger Chang, Laura J. Balcer, Steven L. Galetta, Robin L. Avila, Danette Rutledge, Robert J. Fox
Rok vydání: 2023
Předmět:
Zdroj: CNS Drugs. 37:275-289
ISSN: 1179-1934
1172-7047
DOI: 10.1007/s40263-022-00982-6
Databáze: OpenAIRE
Externí odkaz: